MedPath
NMPA Approval

Ranitidine Hydrochloride and Sodium Chloride Injection

国药准字H20010334

July 16, 2022

国药准字H20010334

Drug Information

盐酸雷尼替丁氯化钠注射液

孚卫

孚卫

注射剂

250ml:雷尼替丁0.1g与氯化钠2.25g

化学药品

July 16, 2022

Company Information

Applicant Company

江西省赣州市赣州经济技术开发区湖边大道209号

Manufacturing Company

江西省赣州市赣州经济技术开发区湖边大道209号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁氯化钠注射液 - NMPA 批准文号 | MedPath